 Home > Encyclopedia > 3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one

3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one

3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one structure

CAS No:
57103-51-2
Formula:
C18H13N3O
Chemical Name:
3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one
Synonyms:
8,13-Dihydroindolo(2',3':3,4)pyrido(1,2-b)(2,7)naphthyridin-5(7H)-one;Indolo(2',3':3,4)pyrido(1,2-b)(2,7)naphthyridin-5(7H)-one, 8,13-dihydro-;nauclefine;parvine;PARVINE;Nauclefine;57103-51-2;UNII-YC1GXM1K1W;NSC266710;YC1GXM1K1W;8,13-Dihydroindolo(2',3':3,4)pyrido(1,2-b)(2,7)naphthyridin-5(7H)-one;8,13-Dihydroindolo[2',3':3,4]pyrido[1,2-b][2,7]naphthyridin-5(7H)-one;NSC 266710;DTXSID50205725;NSC-266710;7,8-Dihydroindolo[2',3':3,4]pyrido[1,2-b][2,7]naphthyridin-5(13H)-one;Indolo(2',3':3,4)pyrido(1,2-b)(2,7)naphthyridin-5(7H)-one, 8,13-dihydro-

Request for Quotation

3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one Basic Attributes

Molecular Weight：

287.3 g/mol

Exact Mass：

287.105862047 g/mol

UNII：

YC1GXM1K1W

NSC Number：

266710

DSSTox ID：

DTXSID50205725

Characteristics

PSA：

49 Å²

Drug Information

MeSH Entry Terms：

8,13-Dihydroindolo(2',3':3,4)pyrido(1,2-b)(2,7)naphthyridin-5(7H)-one

Computed Properties

Molecular Weight:287.3
XLogP3:2.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Exact Mass:287.105862047
Monoisotopic Mass:287.105862047
Topological Polar Surface Area:49
Heavy Atom Count:22
Complexity:517
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Hot Searches: propene; bromobenzene density; sodium hydroxide msds; iron 3 oxide; barium sulfate formula; cefpodoxime proxetil

Guide of 3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one

Basic Attributes
Characteristics
Drug Information
Computed Properties

Request for Quotation



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.